AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, May 1 Asia Pulse - Home grown pharma major Dr Reddys Laboratories (DRL) (BSE:500124) on Wednesday said it will acquire US-based BASF's pharmaceutical contract business and its manufacturing facility for an undisclosed amount.
BASF's business which would be transferred to DRL, includes contract manufacturing of generic prescription and over-the-counter products for branded and generic companies in the United States, DRL said in a filing to the Bombay Stock Exchange.
The acquisition would also include the relevant businesses, customer contracts, trademarks, as well as the manufacturing facility and other assets of BASF in Louisiana.
The manufacturing facility of BASF is designed to manufacture solid, semi-solid and liquid dosage forms and has a proven track record of compliance with ...
Source: HighBeam Research, INDIA'S DRL ACQUIRES US-BASED BASF'S CONTRACT MANUFACTURING BIZ.